Stock Price Quote

ROOPA INDUSTRIES LTD.

NSE : NABSE : 530991ISIN CODE : INE443C01010Industry : Pharmaceuticals & DrugsHouse : TG Venkatesh
BSE49.080 (0 %)
PREV CLOSE ( ) 49.08
OPEN PRICE ( ) 49.72
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 341
TODAY'S LOW / HIGH ( )45.37 50.45
52 WK LOW / HIGH ( ) 38.163.4
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985
Management Info
Tumbalam Gooty Raghavendra - Chairman Tumbalam Gooty Raghavendra - Managing Director
Registered Office

Address 17 / 745,Alur Road,Adoni,
Kurnool Dist,
Andhra Pradesh-518301

Phone 08096330007

Email info@roopaindustries.com

Website www.roopaindustries.com

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE

NEWS

18Aug Roopa Industries submits newspaper pub
Roopa Industries has informed about Submission of Newspaper Clippings w...
20Dec Roopa Industries informs about newspap
Roopa Industries has informed that in compliance with SEBI Circular No...
14Aug Roopa Industries informs about outcome
Roopa Industries has informed that the Board of Directors of the Company..
06Feb Roopa Industries informs about board m
Roopa Industries has informed that a meeting of the Board of Directors o..
19Oct Roopa Industries informs about clarifi
Roopa Industries has informed that the Company has made all necessary di..

Financials

in Millions
QTR Jun 26 ANNUAL 26
Net Profit3.280000000000060.829999999999963
Gross Profit 4.35000000000006 1.68999999999996
Operating Profit 15.500000000000182.79
Net Sales 333.241275.05

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  25999.85 (1.44%)
M.Cap ( in Cr)55247.87
Astrazeneca Pharma (BSE)
peergroup  5831.85 (2.24%)
M.Cap ( in Cr)14579.63
Acutaas Chemicals (BSE)
peergroup  3160.05 (3.33%)
M.Cap ( in Cr)25871.68
Glenmark Pharma. (BSE)
peergroup  2291.25 (3.69%)
M.Cap ( in Cr)64664.73
Pfizer (BSE)
peergroup  3811.25 (1.65%)
M.Cap ( in Cr)17435.60

Shareholding Pattern

NON-INSTITUTION 51.71%
PROMOTERS 48.03%
FII 0.25%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.